DRUG-SPECIFIC INFORMATION GUIDELINES COULD BE DEVELOPED THROUGH USP; 95% COMPLIANCE BY 2006 WOULD BE DIFFICULT TO MEASURE, CONSULTANTS TELL NCPIE
Executive Summary
The U.S. Pharmacopeia's standards development process would be an appropriate mechanism for crafting drug-specific guidelines for patient information, USP Executive Director Jerome Halperin maintained at the Northeast Pharmaceutical Conference in Philadelphia April 10.